Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PTCL”

187 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 187 results

Not applicableLooking for participantsNCT06509945
What this trial is testing

Allo-PBSCT as the First-line Treatment for Patients With the High-risk PTCL

Who this might be right for
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT06724237
What this trial is testing

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeFollicular Helper T-Cell LymphomaFollicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type+1 more
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)UnknownNCT05006664
What this trial is testing

Brentuximab Vedotin in Combination With CHEP in Patient With PTCL

Who this might be right for
Lymphoma, T-Cell, Peripheral
Czech Lymphoma Study Group 33
Early research (Phase 1)Study completedNCT02142530
What this trial is testing

Carfilzomib Plus Belinostat in Relapsed/Refractory NHL

Who this might be right for
Non-Hodgkin LymphomaDiffuse Large B-cell LymphomaMantle Cell Lymphoma+2 more
Massachusetts General Hospital 19
Testing effectiveness (Phase 2)Looking for participantsNCT05963347
What this trial is testing

Go-CHOP as the Frontline Therapy for PTCL

Who this might be right for
Peripheral T Cell Lymphoma
Henan Cancer Hospital 45
Early research (Phase 1)Study completedNCT00355472
What this trial is testing

Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL

Who this might be right for
Adult T-Cell Leukemia and Lymphoma (ATL)Adult Peripheral T-Cell Lymphoma (PTCL)
Kyowa Kirin Co., Ltd. 16
Testing effectiveness (Phase 2)Looking for participantsNCT06810778
What this trial is testing

Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
T-cell-prolymphocytic LeukemiaCutaneous T-Cell Lymphoma Refractory
Jonsson Comprehensive Cancer Center 12
Early research (Phase 1)Study completedNCT05225584
What this trial is testing

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

Who this might be right for
Non Hodgkin Lymphoma (NHL)Peripheral T-cell Lymphoma (PTCL)Cutaneous T-Cell Lymphoma (CTCL)+3 more
Kymera Therapeutics, Inc. 56
Testing effectiveness (Phase 2)Study completedNCT04105010
What this trial is testing

Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8)

Who this might be right for
Relapsed or Refractory Peripheral T Cell Lymphoma
Dizal Pharmaceuticals 171
Testing effectiveness (Phase 2)UnknownNCT02533700
What this trial is testing

CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL

Who this might be right for
Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T Cell LymphomaALK-negative Anaplastic Large Cell Lymphoma+3 more
Shandong Provincial Hospital 106
Testing effectiveness (Phase 2)Ended earlyNCT03075553
What this trial is testing

Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Who this might be right for
Blastic Plasmacytoid Dendritic Cell NeoplasmHepatosplenic T-Cell LymphomaHTLV-1 Infection+14 more
Mayo Clinic 12
Early research (Phase 1)Not Yet RecruitingNCT07192471
What this trial is testing

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Who this might be right for
T-cell NHL (PTCL or CTCL)
Kyowa Kirin, Inc. 72
Testing effectiveness (Phase 2)Looking for participantsNCT06925464
What this trial is testing

CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas

Who this might be right for
T-Cell Non-Hodgkin LymphomaT-cell Lymphoma (PTCL and CTCL)
Beijing GoBroad Hospital 36
Early research (Phase 1)Ended earlyNCT03786926
What this trial is testing

Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas

Who this might be right for
Lymphoma
Hutchmed 53
Testing effectiveness (Phase 2)Ended earlyNCT00632827
What this trial is testing

Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak)

Who this might be right for
Peripheral T-Cell Lymphoma
University of California, San Francisco 21
Early research (Phase 1)Not Yet RecruitingNCT06712173
What this trial is testing

Linperlisib Combined With EZH2 Inhibitor in Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Peripheral T Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 33
Testing effectiveness (Phase 2)UnknownNCT04480125
What this trial is testing

Azacitidine Combined With Chidamide in the Treatment of Newly Diagnosed PTCL Unfit for Conventional Chemotherapy

Who this might be right for
Peripheral T-cell Lymphoma
Ruijin Hospital 28
Large-scale testing (Phase 3)Enrolling By InvitationNCT07258680
What this trial is testing

BrEto-TCL - Defining the Role of Brentuximab and Etoposide for Optimizing First-line Therapy of T-cell Lymphomas

Who this might be right for
Peripheral T-cell Lymphoma
N.N. Petrov National Medical Research Center of Oncology 114
Early research (Phase 1)Looking for participantsNCT05079282
What this trial is testing

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

Who this might be right for
Relapsed or Refractory T Cell Lymphoma
Ono Pharmaceutical Co., Ltd. 217
Testing effectiveness (Phase 2)UnknownNCT03321890
What this trial is testing

Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Peripheral T-cell Lymphoma
Sun Yat-sen University 102
Load More Results
294